SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/47E3FDF3B84967BDE54D527F68D4A5FC5AE3909EAFC5E60318D1DA6D17F43F077BDD0F88290AC55CEB7C943C916DB865>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/47E3FDF3B84967BDE54D527F68D4A5FC5AE3909EAFC5E60318D1DA6D17F43F077BDD0F88290AC55CEB7C943C916DB865
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/47E3FDF3B84967BDE54D527F68D4A5FC5AE3909EAFC5E60318D1DA6D17F43F077BDD0F88290AC55CEB7C943C916DB865
http://www.w3.org/2000/01/rdf-schema#comment
"Statins can reduce EL expression in vitro and in vivo via inhibition of RhoA activity. The inhibition of EL expression in the vessel wall may contribute to the anti-atherogenic effects of statins."
xsd:string
http://purl.uniprot.org/uniprot/#_6A9E5FF9B2D7CEF93A989D366DB89CBD8AFD3BCD15E79A488138B52B83F0EB65C10CD7A8E7C44A6D4862AC7E242FC3CF
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/47E3FDF3B84967BDE54D527F68D4A5FC5AE3909EAFC5E60318D1DA6D17F43F077BDD0F88290AC55CEB7C943C916DB865
http://purl.uniprot.org/uniprot/Q9WVG5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/47E3FDF3B84967BDE54D527F68D4A5FC5AE3909EAFC5E60318D1DA6D17F43F077BDD0F88290AC55CEB7C943C916DB865
http://purl.uniprot.org/uniprot/#_Q9WVG5-mappedCitation-20045866
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/47E3FDF3B84967BDE54D527F68D4A5FC5AE3909EAFC5E60318D1DA6D17F43F077BDD0F88290AC55CEB7C943C916DB865